Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.
Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?
Acquired channelopathies as contributors to development and progression of multiple sclerosis.
AMPYRA® two-year safety data presented at 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome.
Autoregulatory CD8 T cells depend on cognate antigen recognition and CD4/CD8 myelin determinants.
MENGA: A New Comprehensive Tool for the Integration of Neuroimaging Data and the Allen Human Brain Transcriptome Atlas.
Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status.
Passive induction of experimental allergic encephalomyelitis.
B-cell-directed therapy: which B cells should be targeted and how?
The role of endogenous antiradical protective system in multiple sclerosis.
Transcriptional targeting of DCs with lentiviral vectors induces antigen-specific tolerance in a mouse model of multiple sclerosis.
Myelination of rodent hippocampal neurons in culture.
FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system.
Hierarchical conditional random fields for detection of gad-enhancing lesions in multiple sclerosis.
Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis.
P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma.
Obstetrical epidural and spinal anesthesia in multiple sclerosis.
Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis.
FTY720 attenuates excitotoxicity and neuroinflammation.
Longitudinal study of alexithymia and multiple sclerosis.
Sphingolipids in ocular inflammation.
Orally Active 7-Substituted (4-Benzyl-phthalazin-1-yl)-2-methyl-piperazin-1-yl]-nicotinonitriles as Active-site Inhibitors of Sphingosine-1-Phosphate Lyase for the Treatment of Multiple Sclerosis.
Effect of fingolimod (FTY720) on cerebral blood flow, platelet function, and macular thickness in healthy volunteers.
Increased oligodendrogenesis by humanin promotes axonal remyelination and neurological recovery in hypoxic/ischemic brains.

Pages